Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach

por Englmeier, Fabienne, Bleckmann, Annalen, Brückl, Wolfgang, Griesinger, Frank, Fleitz, Annette, Nagels, Klaus
Publicado 2022

Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)

por Faehling, Martin, Witte, Hanno, Sebastian, Martin, Ulmer, Matthias, Sätzler, Rainer, Steinestel, Konrad, Brückl, Wolfgang M., Evers, Georg, Büschenfelde, Christian Meyer zum, Bleckmann, Annalen
Publicado 2022

Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP

por Faehling, Martin, Schumann, Christian, Christopoulos, Petros, Hoffknecht, Petra, Alt, Jürgen, Horn, Marlitt, Eisenmann, Stephan, Schlenska-Lange, Anke, Schütt, Philipp, Steger, Felix, Brückl, Wolfgang M., Christoph, Daniel C.
Publicado 2020

Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice

por Brückl, Wolfgang M., Reck, Martin, Griesinger, Frank, Schäfer, Harald, Kortsik, Cornelius, Gaska, Tobias, Rawluk, Justyna, Krüger, Stefan, Kokowski, Konrad, Budweiser, Stephan, Ficker, Joachim H., Hoffmann, Christopher, Schüler, Andrea, Laack, Eckart
Publicado 2021